Efficacy and safety of ivabradine in patients with chronic systolic heart failure and low blood pressure in the shift trial

被引：0
|
作者：
Komajda, M. [1 ]
Bohm, M. [2 ]
Borer, J. [3 ,4 ]
Ford, I. [5 ]
Robertson, M. [5 ]
Manolis, A. [6 ]
Tavazzi, L. [7 ]
Swedberg, K. [8 ]
机构：
[1] Univ Paris 06, Dept Cardiol, Hop La Pitie Salpetriere, Paris, France
[2] Univ Saarlandes Kliniken, Innere Med Klin 3, Homburg, Germany
[3] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA
[4] Suny Downstate Med Ctr, Dept Med, New York, NY USA
[5] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[6] Asklepeion Hosp, Dept Cardiol, Athens, Greece
[7] Ettore Sansavini Hlth Sci Fdn, Maria Cecilia Hosp GVM Care & Res, Cotignola, Italy
[8] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure and Low Blood Pressure in the SHIFT Trial
    Komajda, Michel
    Bohm, Michael
    Borer, Jeff
    Ford, Ian
    Robertson, Michele
    Manolis, Athanasios
    Tavazzi, Luigi
    Swedberg, Karl
    [J]. JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S38 - S38
  • [2] Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Robertson, Michele
    Manolis, Athanasios J.
    Tavazzi, Luigi
    Swedberg, Karl
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (07) : 810 - 816
  • [3] Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
    Komajda, Michel
    Tavazzi, Luigi
    Francq, Bernard G.
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Swedberg, Karl
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (12) : 1294 - 1301
  • [4] Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial
    Borer, J. S.
    Bohm, M.
    Ford, I.
    Komajda, M.
    Tavazzi, L.
    Swedberg, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S151 - S151
  • [5] Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)
    Borer, Jeffrey S.
    Boehm, Michael
    Ford, Ian
    Robertson, Michele
    Komajda, Michel
    Tavazzi, Luigi
    Swedberg, Karl
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (03): : 497 - 503
  • [6] Ivabradine in patients with chronic heart failure and low blood pressure
    Bagriy, A. E.
    Schukina, E. V.
    Samoilova, O. V.
    Pricolota, O. A.
    Malovichko, S. I.
    Gukov, A. G.
    Vorobiev, A. S.
    Pricolota, A. V.
    Bagriy, E. A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 264 - 264
  • [7] Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
    Das, Debraj
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Fu, Michael
    Howlett, Jonathan
    Ezekowitz, Justin A.
    Lund, Lars H.
    [J]. CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [8] Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial
    Bohm, Servier M.
    Borer, J. S.
    Ford, I.
    Lainscak, M.
    Komajda, M.
    Robertson, M.
    Tavazzi, L.
    Swedberg, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 266 - 266
  • [9] Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial
    Boehm, Michael
    Robertson, Michele
    Borer, Jeffrey
    Ford, Ian
    Komajda, Michel
    Mahfoud, Felix
    Ewen, Sebastian
    Swedberg, Karl
    Tavazzi, Luigi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [10] Efficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: Results of the COPERNICUS study
    Rouleau, JL
    Fowler, MB
    Krum, H
    Katus, HA
    Coats, AJ
    Tendera, M
    Mohacsi, P
    Amann-Zalan, I
    Holcslaw, TL
    Roecker, EB
    Packer, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 171A - 172A
12345